CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013 1Q13 New Subscribers Up 28.3% to 16,460 1Q13 Revenue Up 31.9% YOY to RMB115.3 Million 1Q13 Operating Income Up 44.4% to RMB44.4 Million Conference Call to be Held August 23, 2012 at 8:00 a.m. ET HONG KONG, China, August 22, 2012 — China Cord Blood Corporation]

By | 2016-02-29T14:33:18+00:00 August 22nd, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Reports Financial Results for the First Quarter of Fiscal 2013 1Q13 New Subscribers Up 28.3% to 16,460 1Q13 Revenue Up 31.9% YOY to RMB115.3 Million 1Q13 Operatingome Up 44.4% to RMB44.4 Millionnferencell to be Held August 23, 2012 at 8:00 a.m. ET HONG KONG, China, August 22, 2012 Chinard Bloodrporation (NYSE:) (CCBC or]

By | 2016-02-04T16:42:58+00:00 August 22nd, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] F-3/A: Subject tompletion,ted August 20, 2012 PROSPECTUS 22,903,454 Ordinary

[Subject tompletion,ted August 20, 2012 PROSPECTUS 22,903,454 Ordinary Shares CHINARD BLOODRPORATION This prospectus relates to the resale of up to 22,903,454 ordinary shares, par value $0.0001 per share (thenversion Shares), issuable uponnversion of $65,000,000 currently outstandinggregate principal amount of our 7% seniornvertible notes due 2017 (thenvertible Notes). Thenversion Shares are being offered by the selling]

By | 2016-02-04T16:44:54+00:00 August 20th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[Execution Copy SHARE PURCHASE AGREEMENT among CHINA CORD BLOOD CORPORATION and CORDLIFE GROUP LIMITED Dated August 15, 2012 Table of Contents Page Section 1 INTERPRETATION 2 Section 2 sALE AND PURCHASE OF THE SALE SHARES 8 Section 3 CONDITIONS PRECEDENT TO COMPLETION 8 Section 4 COMPLETION ACTIONS 12 14 14 Section 7 CONFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS 15] [EXECUTION COPY th DATED THIS 15 Between CHINA STEM CELLS (SOUTH) COMPANY LIMITED and Cordlife (Hong Kong) Limited SHARES REPURCHASE AGREEMENT relating to the repurchase of 100 ordinary shares in CHINA STEM CELLS (SOUTH) COMPANY LIMITED TABLE OF CONTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 3 2. REPURCHASE OF THE REPURCHASED SHARES 5 3. CONDITIONS 6 4. CONSIDERATION FOR] [China Cord Blood Corporation and Cordlife Group Limited HONG KONG, China, August 15, 2012 -- China Cord Blood Corporation "CCBC's prominent leadership in the industry clearly speaks to its presence in China. In recent years, it has successfully brought the benefits of umbilical cord blood banking to numerous people in multiple regions across China," commented Mr. Jeremy Yee. "CCBC's management]

By | 2016-02-29T14:35:32+00:00 August 15th, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: Execution Copy SHARE PURCHASE AGREEMENT among CHINA CORD

[Execution Copy SHARE PURCHASE AGREEMENT among CHINA CORD BLOOD CORPORATION and CORDLIFE GROUP LIMITED Dated August 15, 2012 Table of Contents Page Section 1 INTERPRETATION 2 Section 2 sALE AND PURCHASE OF THE SALE SHARES 8 Section 3 CONDITIONS PRECEDENT TO COMPLETION 8 Section 4 COMPLETION ACTIONS 12 14 14 Section 7 CONFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS 15] [EXECUTION COPY th DATED THIS 15 Between CHINA STEM CELLS (SOUTH) COMPANY LIMITED and Cordlife (Hong Kong) Limited SHARES REPURCHASE AGREEMENT relating to the repurchase of 100 ordinary shares in CHINA STEM CELLS (SOUTH) COMPANY LIMITED TABLE OF CONTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 3 2. REPURCHASE OF THE REPURCHASED SHARES 5 3. CONDITIONS 6 4. CONSIDERATION FOR] [China Cord Blood Corporation and Cordlife Group Limited HONG KONG, China, August 15, 2012 -- China Cord Blood Corporation "CCBC's prominent leadership in the industry clearly speaks to its presence in China. In recent years, it has successfully brought the benefits of umbilical cord blood banking to numerous people in multiple regions across China," commented Mr. Jeremy Yee. "CCBC's management]

By | 2016-02-29T14:37:18+00:00 August 15th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Executionpy SHARE PURCHASEREEMENT among CHINARD BLOODRPORATION andRDLIFE LIMITEDted August 15, 2012 Table ofntents Page Section 1 INTERPRETATION 2 Section 2LE AND PURCHASE OF THELE SHARES 8 Section 3NDITIONS PRECEDENT TOMPLETION 8 Section 4MPLETION ACTIONS 12 14 14 Section 7NFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS] [EXECUTIONPY thTED THIS 15 Between CHINA STEM CELLS (SOUTH)MPANY LIMITED andrdlife (Hong Kong) Limited SHARES REPURCHASEREEMENT relating to the repurchase of 100 ordinary shares in CHINA STEM CELLS (SOUTH)MPANY LIMITED TABLE OFNTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 3 2. REPURCHASE OF THE REPURCHASED SHARES] [Chinard Bloodrporation andrdlife Limited HONG KONG, China, August 15, 2012 -- Chinard Bloodrporation "CCBC's prominent leadership in the industry clearlyeaks to its presence in China. In recent years, it has successfully brought the benefits of umbilicalrd blood banking to numerous people in multiple regions across China,"mmented Mr. Jeremy Yee. "CCBC's management teamnsistently demonstrates their uniqueility]

By | 2016-02-04T16:46:23+00:00 August 15th, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: Executionpy SHARE PURCHASEREEMENT among CHINARD BLOODRPORATION andRDLIFE LIMITEDted

[Executionpy SHARE PURCHASEREEMENT among CHINARD BLOODRPORATION andRDLIFE LIMITEDted August 15, 2012 Table ofntents Page Section 1 INTERPRETATION 2 Section 2LE AND PURCHASE OF THELE SHARES 8 Section 3NDITIONS PRECEDENT TOMPLETION 8 Section 4MPLETION ACTIONS 12 14 14 Section 7NFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS] [EXECUTIONPY thTED THIS 15 Between CHINA STEM CELLS (SOUTH)MPANY LIMITED andrdlife (Hong Kong) Limited SHARES REPURCHASEREEMENT relating to the repurchase of 100 ordinary shares in CHINA STEM CELLS (SOUTH)MPANY LIMITED TABLE OFNTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 3 2. REPURCHASE OF THE REPURCHASED SHARES] [Chinard Bloodrporation andrdlife Limited HONG KONG, China, August 15, 2012 -- Chinard Bloodrporation "CCBC's prominent leadership in the industry clearlyeaks to its presence in China. In recent years, it has successfully brought the benefits of umbilicalrd blood banking to numerous people in multiple regions across China,"mmented Mr. Jeremy Yee. "CCBC's management teamnsistently demonstrates their uniqueility]

By | 2016-02-04T16:46:51+00:00 August 15th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] F-3:

[] [[Conyers Dill & Pearman(Cayman) Limited letterhead] 8 August 2012 Matter No.:877099 Doc Ref: 1700446 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation th 48 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the “Company”) Registration Statement Commission Securities Act Ordinary Shares Convertible Notes (the “ We have acted as special Cayman] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 31, 2012, with respect to the consolidated balance sheets of China Cord Blood Corporation and subsidiaries as of March 31, 2011 and 2012, and the related consolidated statements of comprehensive income, changes in equity, and] [9 5层 6层 中国北京市西城区金融大街甲 邮 编码 100033 电话 8610 66523388 传 8610 66523399 5-6/F South Tower, Financial Street Center, A9 Financial Street, Xicheng District, Beijing, 100033, P.R.C. Tel: (8610) 66523388 / Fax: (8610) 66523399 August 8, 2012 China Cord Blood Corporation 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Madams and Sirs, Yours faithfully, JunZeJun]

By | 2016-02-29T14:38:59+00:00 August 8th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] F-3: CALCULATION OF REGISTRATION FEE Titleofeachclassofsecuritiestoberegistered Amounttobe Proposed Proposed

[CALCULATION OF REGISTRATION FEE Titleofeachclassofsecuritiestoberegistered Amounttobe Proposed Proposed Amountof Ordinary shares, par value $0.0001 per share(4) 22,903,454 $ 2.838 $ 65,000,003 $ 7,450 (1) Represents the maximumgregate number of thempanys ordinary shares, par value $0.0001 per share receivable uponnversion of $65,000,000 currently outstandinggregate principal amount of thempanys 7% Seniornvertible Notes due 2017.] [[Conyers Dill & Pearman(Cayman) Limited letterhead] 8 August 2012 Matter No.:877099 Doc Ref: 1700446 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com Chinard Bloodrporation th 48 1 Garden Road, Central Hong KongR. Dear Sirs, Re: Chinard Bloodrporation (thempany) Registration Statementmmission Securities Act Ordinary Sharesnvertible Notes] [Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation: Wensent to the use of our reportsted July 31, 2012, with respect to thensolidated balance sheets of Chinard Bloodrporation and subsidiaries of March 31, 2011 and 2012, and the relatednsolidated statements ofmprehensiveome, changes in equity, andsh flows for each of the years] [9 5 6 100033 8610 66523388 8610 66523399 5-6/F South Tower, Financial Street Center, A9 Financial Street, Xicheng District, Beijing, 100033, P.R.C. Tel: (8610) 66523388 / Fax: (8610) 66523399 August 8, 2012 Chinard Bloodrporation 48th Floor, Bank of China Tower 1 Garden Road Central Hong KongR. Madams and Sirs,]

By | 2016-02-04T16:48:46+00:00 August 8th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar